You are here

Home » Industry » Scheduling of medicines & poisons » Public notices about scheduling » Reasons for scheduling delegate's final decisions

Notice of final decisions to amend (or not amend) the current Poisons Standard, November 2020

Scheduling medicines and poisons

25 November 2020

1 Notice of final decisions to amend (or not amend) the current Poisons Standard

This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS and 42ZCZX, this notice publishes:

  1. the decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR and 42ZCZU;
  2. the reasons for those final decisions; and
  3. the date of effect of those decisions.

2 Final decisions in relation to nicotine and cannabidiol (private application and delegate initiated)

Note that the final decisions on nicotine and cannabidiol (private application and delegate initiated) are not published in this notice. Publication is expected in mid December and late December 2020, respectively.

Final decisions and reasons

How to access a pdf or Word document

We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au (for substances referred to the ACMS or Joint ACCS-ACMS) or chemicals.scheduling@health.gov.au (for substances referred to the ACCS).

Contents

  • 1 Notice of final decisions to amend (or not amend) the current Poisons Standard
  • 2 Final decisions in relation to nicotine and cannabidiol (private application and delegate initiated)
  • 3 Final decisions on proposed amendments to the current Poisons Standard under regulation 42ZCZR
    • 3.1 Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #31, June 2020)
      • 3.1.1 Final decision in relation to oxymetazoline
      • 3.1.2 Final decision in relation to eletriptan
      • 3.1.3 Final decision in relation to clotrimazole
      • 3.1.4 Final decision in relation to sildenafil
      • 3.1.5 Final decision in relation to ibuprofen
      • 3.1.6 Final decision in relation to cumyl-pegaclone
  • 4 Final decisions on proposed amendments to the current Poisons Standard under regulation 42ZCZU
    • 4.1 Final decision in relation to bupivacaine
    • 4.2 Final decision in relation to lidocaine (lignocaine)
    • 4.3 Final decision in relation to Bovine Ephemeral Fever vaccine
    • 4.4 Final decision in relation to fluazaindolizine
    • 4.5 Final decision in relation to florylpicoxamid